Asian Research Council is Awarding Alzther Industries with “Asia’s Most Innovative Company of the Year”
Asian’s Council Minister of Research presented the awards at the Research Council's annual Evening of Excellence event.
- (1888PressRelease) May 08, 2018 - Alzther Industries (ISIN: KR7119857621) a start-up biotechnology company, focused on diseases associated with protein misfolding and which is developing drugs to halt the progression of Alzheimer’s disease and companion diagnostics for the early detection of Alzheimer’s disease, today announced that it can boast the title of Asia's Most Innovative Company of the Year, in recognition of the firm’s revolutionary diagnostics method based on a simple blood test.
A blood sample is all that Alzther Industries needs to determine whether a patient has breast cancer, Alzheimer’s or Parkinson’s disease. Over 100 Asian business leaders voted to crown this developer of a ground-breaking diagnostics method as Asia’s Most Innovative Company of the Year. The biotechnology firm won an overwhelming majority of the votes as industry’s own representatives selected the winner from six companies nominated by the Research Council.
“This is an important acknowledgement, being chosen by peers who know how complicated it is to commercialise research findings,” says Dr. Sung Hwan-Kuk, Chief Executive Officer of Alzther Industries.
“Early, correct diagnosis makes it possible to treat and plan more effectively. A correct diagnosis is also critical to enable the pharmaceutical industry to develop new, more effective medicines,” says the firm’s Marketing Director, Mr. Jin Cheung.
The researchers from Alzther Industries hit upon the idea that this same biological communication may also be used for diagnostics in humans. By examining changes in gene activity in, for example, the blood, they believed they could recognise disease developing elsewhere in the body.
Currently the company is receiving funding for User-driven Research-based Innovation. This public funding, as well as a large group of shareholders that has long supported our project, have been essential to our success. It takes a very long time for an innovative idea to gain acceptance – and a long time before one can actually earn money from it,” adds Marketing Director Mr. Jin Cheung.
About Alzther Industries (ISIN: KR7119857621)
Alzther Industries is a startup biotechnology company supported by various grants and private investors. The funds and our investors support projects with a high potential for future innovations. Alzther Industries is focused on diseases associated with protein misfolding. The company is currently developing drugs to halt the progression of Alzheimer’s disease and companion diagnostics for the early detection of Alzheimer’s disease. Alzther Industries is focused on drug development until phase II clinical studies. The location of the company in Seoul enables the access to experienced experts in the field of drug discovery and development, as well as business development and commercialization.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam